头孢呋辛序贯治疗儿童下呼吸道感染的经济学评价

目的:探讨头孢呋辛序贯治疗与持续静脉滴注治疗儿童下呼吸道感染的经济效果。方法:从本院呼吸内科病案中选择88例儿童下呼吸道感染病例,分为治疗组(序贯疗法)与对照组(持续静脉滴注),以2组治疗总有效率和1个疗程的治疗费用为依据,运用药物经济学的最小成本分析法进行评价。结果:治疗组与对照组的痊愈率分别为67.44%、75.56%(P>0.05),总有效率分别为86.05%、88.89%(P>0.05),总费用分别为(1 434.14±182.51)、(1 927.73±378.98)元(P<0.001)。结论:头孢呋辛序贯疗法较佳。

An Economic Evaluation of Sequential Therapy with Cefuroxime for Children with Lower Respiratory Infection

OBJECTIVE: To study the economic effect of sequential therapy with cefuroxime and that of persistent intravenous drop infusion with Axetine(cefuroxime) for children with lower respiratory tract infection.METHODS: 88 cases of children with lower respiratory infection were chosen from the respiratory department of our hospital,and divided into the treatment group(by sequential therapy) and control group(by persistent intravenous drop infusion with Axetine).A cost-minimization analysis of pharmacoeconomics was conducted on one-treatment course costs and overall efficacy rates of respective group.RESULTS: The treatment group and control group reported respective recovery rates of 67.44% and 75.56%(P>0.05),overall efficacy rates of 86.05% and 88.89%(P>0.05),and total costs of(1 434.14± 182.51) yuan and(1 927. 73± 378.98) yuan(P<0.001).CONCLUSION: Sequential therapy with Axetine(cefuroxime) is a more cost-effective approach.